Since amylin is considered as the initiator of events leading to neurotoxicity and the clinical symptoms of Alzheimer's disease, the hunt for anti-amyloid therapies has become a significant strategy in Alzheimer's disease-related study 50-52. The gene discussed is IAPP; the disease is early-onset autosomal dominant Alzheimer disease.